Sekhar LN, Bucur SD, Bank WO, Wright DC
Department of Neurosurgery, George Washington University Medical Center, Washington, District of Columbia 20037, USA.
Neurosurgery. 1999 Jun;44(6):1207-23; discussion 1223-4. doi: 10.1097/00006123-199906000-00028.
In the treatment of patients with cranial base tumors, unclippable aneurysms, or medically intractable ischemia, it may be necessary to use high-flow bypass grafts. The indications, surgical techniques and complications are discussed. METHODS: During a 10-year period, 99 saphenous vein grafts and 3 radial artery grafts were performed for 101 patients, i.e., 72 with neoplasms, 23 with aneurysms, and 6 with ischemia. Clinical follow-up monitoring of the patients was by direct examination or telephone interview, with a mean follow-up period of 41.2 months (range, 5-147 mo). Radiological follow-up monitoring was by magnetic resonance imaging, magnetic resonance angiography, or three-dimensional computed tomographic angiography, with a mean follow-up period of 32 months (range, 1-120 mo). During the follow-up period, there was one late graft occlusion and one graft stenosis. RESULTS: The use of intraoperative angiography improved the patency rate from 90 to 98% and reduced the incidence of perioperative stroke from 13 to 9.5%. Ninety-two percent of the patients were in excellent or good neurological condition at the time of discharge from the hospital, compared with 95% before surgery. The perioperative mortality rate was 2%. Other complications included three intracranial hematomas, rupture of a vein graft in a patient with Marfan's syndrome, and five tumor resection-related problems. The long-term survival rates for patients who received grafts were excellent for patients with benign tumors, fair to poor for patients with malignant tumors, good for patients with aneurysms, and excellent for patients with ischemia. CONCLUSION: The results of saphenous vein and radial artery grafting have been greatly improved by the use of intraoperative angiography, improvements in surgical techniques, and improved perioperative treatment.
在治疗颅底肿瘤、无法夹闭的动脉瘤或药物治疗难以控制的缺血性疾病患者时,可能需要使用高流量搭桥移植物。本文讨论了其适应证、手术技术及并发症。方法:在10年期间,为101例患者进行了99例大隐静脉移植和3例桡动脉移植,其中72例为肿瘤患者,23例为动脉瘤患者,6例为缺血性疾病患者。通过直接检查或电话访谈对患者进行临床随访监测,平均随访期为41.2个月(范围5 - 147个月)。通过磁共振成像、磁共振血管造影或三维计算机断层血管造影进行影像学随访监测,平均随访期为32个月(范围1 - 120个月)。随访期间,发生1例移植血管晚期闭塞和1例移植血管狭窄。结果:术中血管造影的使用使通畅率从90%提高到98%,围手术期卒中发生率从13%降低到9.5%。92%的患者出院时神经功能状况为优或良,术前这一比例为95%。围手术期死亡率为2%。其他并发症包括3例颅内血肿、1例马凡综合征患者静脉移植物破裂以及5例与肿瘤切除相关的问题。接受移植的患者中,良性肿瘤患者的长期生存率极佳,恶性肿瘤患者的生存率为中等到差,动脉瘤患者的生存率良好,缺血性疾病患者的生存率极佳。结论:术中血管造影的使用、手术技术的改进以及围手术期治疗的改善,使大隐静脉和桡动脉移植的效果有了显著提高。